Report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry
Rowlings, P.A.; Horowitz, M.M.; Armitage, J.O.; Gale, R.P.; Sobocinski, K.A.; Zhang, M.J.; Bortin, M.M.
Clinical transplants 1993: 101-108
1993
ISSN/ISBN: 0890-9016 PMID: 7918143 Document Number: 417429
The Statistical Center of the IBMTR/NAABMTR has expanded its role from collecting data on allogeneic and syngeneic transplants to the area of autologous bone marrow and blood cell transplantation given to support high-dose therapies for cancer. In diseases such as acute leukemia for which both allogeneic and autotransplants are performed, direct comparisons of outcomes of these therapies are now possible. The large number of cases that has accrued rapidly into the NAABMTR (over 9,000 since 1989) will allow us to use sophisticated statistical techniques to determine potential benefits and disadvantages in the rapidly growing area of autotransplantation.